drugset / Trial / NCT02158221

PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load

NCT02158221

Completed 32 enrolled Danish Headache Center
Non-randomizedParallel-groupDouble-blind

Summary

The investigators hypothesized that migraine without patients with many genetic loci associated with migraine (high genetic load) would be more sensitive and get provoked more migraine attacks by PACAP compared to patients with few genetic loci associated with migraine (low genetic load).

Timeline

Start
2014-06
Primary completion
2014-11
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lu AG09222 Monoclonal antibody 1.5 ug Intravenous

Indications